Oral NRC-2694-A in combination with paclitaxel as therapy for recurrent and/or metastatic head and neck squamous cell carcinoma (R/M-HNSCC) that progressed on or after an immune checkpoint inhibitor (ICI): A multi-center, single-arm, phase 2 trial
Adkins, Douglas, Oppelt, Peter John, Ley, Jessica C., Myneni, Praveen Chowdary, Gogula, Venkata Ramana, Kanumuri, Satish, Yadla, Sheshubabu, Sadu, Venkata, Kota, Raghava, Sanagala, Saipavan, Surapaneni, Mounika
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article